SEC Form 4 · accession 0001645627-17-000130

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · 10% Owner

Period of report

Oct 17, 2017

Accepted (ET)

Oct 23, 2017 · 1:20 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Oct 17, 2017	P	2,000	$0.062	A	23,828,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0644	A	23,830,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0695	A	23,832,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0695	A	23,834,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0695	A	23,836,189	D
Common Stock	Oct 17, 2017	P	1,350	$0.0672	A	23,837,539	D
Common Stock	Oct 17, 2017	P	2,650	$0.0695	A	23,840,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0695	A	23,842,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0695	A	23,844,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0698	A	23,846,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0698	A	23,848,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0698	A	23,850,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0698	A	23,852,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0709	A	23,854,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0702	A	23,856,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.0704	A	23,858,189	D
Common Stock	Oct 17, 2017	P	3,000	$0.0698	A	23,861,189	D
Common Stock	Oct 17, 2017	P	2,000	$0.07	A	23,863,189	D
Common Stock	Oct 18, 2017	P	2,000	$0.0698	A	23,865,189	D
Common Stock	Oct 18, 2017	P	2,000	$0.07	A	23,867,189	D
Common Stock	Oct 18, 2017	P	3,000	$0.065	A	23,870,189	D
Common Stock	Oct 18, 2017	P	2,000	$0.0695	A	23,872,189	D
Common Stock	Oct 18, 2017	P	2,000	$0.069	A	23,874,189	D

No Table II lines on this filing.